176 related articles for article (PubMed ID: 21281896)
1. Stereotactic radiotherapy of primary lung cancer and other targets: results of consultant meeting of the International Atomic Energy Agency.
Nagata Y; Wulf J; Lax I; Timmerman R; Zimmermann F; Stojkovski I; Jeremic B
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):660-9. PubMed ID: 21281896
[TBL] [Abstract][Full Text] [Related]
2. Treatment of large stage I-II lung tumors using stereotactic body radiotherapy (SBRT): planning considerations and early toxicity.
Ong CL; Palma D; Verbakel WF; Slotman BJ; Senan S
Radiother Oncol; 2010 Dec; 97(3):431-6. PubMed ID: 20971523
[TBL] [Abstract][Full Text] [Related]
3. Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy Group.
Nagata Y; Hiraoka M; Mizowaki T; Narita Y; Matsuo Y; Norihisa Y; Onishi H; Shirato H
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):343-7. PubMed ID: 19735861
[TBL] [Abstract][Full Text] [Related]
4. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis.
Macdonald OK; Kruse JJ; Miller JM; Garces YI; Brown PD; Miller RC; Foote RL
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):950-8. PubMed ID: 19801106
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer : Literature review and practice recommendations of the DEGRO Working Group on Stereotactic Radiotherapy.
Panje C; Andratschke N; Brunner TB; Niyazi M; Guckenberger M
Strahlenther Onkol; 2016 Dec; 192(12):875-885. PubMed ID: 27778052
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic, high single-dose irradiation of stage I non-small cell lung cancer (NSCLC) using four-dimensional CT scans for treatment planning.
Fritz P; Kraus HJ; Blaschke T; Mühlnickel W; Strauch K; Engel-Riedel W; Chemaissani A; Stoelben E
Lung Cancer; 2008 May; 60(2):193-9. PubMed ID: 18045732
[TBL] [Abstract][Full Text] [Related]
7. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322
[TBL] [Abstract][Full Text] [Related]
8. Dose-volume comparison of proton radiotherapy and stereotactic body radiotherapy for non-small-cell lung cancer.
Kadoya N; Obata Y; Kato T; Kagiya M; Nakamura T; Tomoda T; Takada A; Takayama K; Fuwa N
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1225-31. PubMed ID: 20732759
[TBL] [Abstract][Full Text] [Related]
9. [Stereotactic body radiotherapy for malignant nodules in the lung].
Nestle U; Guckenberger M
Zentralbl Chir; 2013 Oct; 138 Suppl 1():S25-31. PubMed ID: 24150852
[TBL] [Abstract][Full Text] [Related]
10. Impact of IMRT and leaf width on stereotactic body radiotherapy of liver and lung lesions.
Dvorak P; Georg D; Bogner J; Kroupa B; Dieckmann K; Pötter R
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1572-81. PubMed ID: 15817364
[TBL] [Abstract][Full Text] [Related]
11. Double-scattered proton-based stereotactic body radiotherapy for stage I lung cancer: a dosimetric comparison with photon-based stereotactic body radiotherapy.
Hoppe BS; Huh S; Flampouri S; Nichols RC; Oliver KR; Morris CG; Mendenhall NP; Li Z
Radiother Oncol; 2010 Dec; 97(3):425-30. PubMed ID: 20934768
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer.
Hiraoka M; Matsuo Y; Nagata Y
Cancer Radiother; 2007; 11(1-2):32-5. PubMed ID: 17158081
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic radiotherapy for peripheral lung tumors: a comparison of volumetric modulated arc therapy with 3 other delivery techniques.
Ong CL; Verbakel WF; Cuijpers JP; Slotman BJ; Lagerwaard FJ; Senan S
Radiother Oncol; 2010 Dec; 97(3):437-42. PubMed ID: 21074878
[TBL] [Abstract][Full Text] [Related]
14. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer.
Grills IS; Mangona VS; Welsh R; Chmielewski G; McInerney E; Martin S; Wloch J; Ye H; Kestin LL
J Clin Oncol; 2010 Feb; 28(6):928-35. PubMed ID: 20065181
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic radiotherapy of primary lung cancer and other targets: results of consultant meeting of the International Atomic Energy Agency (Int J Radiat Oncol Biol Phys 2011;79:660-669).
Atalar B; Caglar H; Ozyar E
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):521; author reply 521. PubMed ID: 22244280
[No Abstract] [Full Text] [Related]
16. Tomotherapeutic stereotactic body radiation therapy: Techniques and comparison between modalities.
Fuss M; Shi C; Papanikolaou N
Acta Oncol; 2006; 45(7):953-60. PubMed ID: 16982563
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiotherapy versus surgery for medically operable Stage I non-small-cell lung cancer: a Markov model-based decision analysis.
Louie AV; Rodrigues G; Hannouf M; Zaric GS; Palma DA; Cao JQ; Yaremko BP; Malthaner R; Mocanu JD
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):964-73. PubMed ID: 20932688
[TBL] [Abstract][Full Text] [Related]
18. Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma.
Nguyen NP; Garland L; Welsh J; Hamilton R; Cohen D; Vinh-Hung V
Cancer Treat Rev; 2008 Dec; 34(8):719-27. PubMed ID: 18657910
[TBL] [Abstract][Full Text] [Related]
19. Aggravation of dyspnea in stage I non-small cell lung cancer patients following stereotactic body radiotherapy: Is there a dose-volume dependency?
Paludan M; Traberg Hansen A; Petersen J; Grau C; Høyer M
Acta Oncol; 2006; 45(7):818-22. PubMed ID: 16982545
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung cancer--updates of radiobiology, techniques, and clinical outcomes.
Hadziahmetovic M; Loo BW; Timmerman RD; Mayr NA; Wang JZ; Huang Z; Grecula JC; Lo SS
Discov Med; 2010 May; 9(48):411-7. PubMed ID: 20515609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
